Psychological Burden in ICU Survivors of Severe COVID-19 Pneumonia, Their Relatives and Their Healthcare Providers
BURDENCOV
"Psychological Burden in ICU Survivors of Severe COVID-19 Pneumonia, Their Relatives and Their Healthcare Providers" "Impact Psychologique de l'épidémie COVID-19 Chez Les Patients, Familles et Soignants de Reanimation" "BURDENCOV"
1 other identifier
observational
1,464
1 country
3
Brief Summary
Coronavirus disease 2019 (COVID-19) is an infectious disease responsible for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The infection is highly contagious requiring restrictive and stressful measures for patients, family members and ICU healthcare providers. To avoid contagion, patient isolation has become the rule. For patients, these measures add stress to the ICU environment and deprive them of unrestricted family visits. Family members are not only left with fear but also many unanswered questions. In end-of-life situations, many family members are unable to say good-bye and unable to provide support to their loved-one throughout the process. The impact of exclusion or limited inclusion certainly needs to be explored. Moreover, ICU caregivers are having to face new challenges and to work in a unknown situation, juggling with both professional issues such as increased workload, working longer hours and safety issues, and personal issues such as child care and transport as well as family transmission of the virus. The main objective of this study is to demonstrate that the COVID-19 pandemic, as compared to seasonal flu and community acquired pneumonia, significantly increases post-traumatic stress disorder (PTSD) in family members of critically ill patients. PTSD-related symptoms will be assessed in family members using the IES-R (impact of event scale revised) during a telephone interview 90 days after ICU discharge. The IES-R is a 22-item self-report measure that assesses subjective distress caused by traumatic events. It will be compared across the three groups (COVID-19, FLU and CAP).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2020
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 6, 2020
CompletedFirst Submitted
Initial submission to the registry
April 7, 2020
CompletedFirst Posted
Study publicly available on registry
April 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedOctober 6, 2020
October 1, 2020
8 months
April 7, 2020
October 5, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
PTSD Family members sup 22
Proportion of Family members with IES-R\> 22 PTSD-related symptoms will be assessed in family members using the IES-R (impact of event scale revised) during a telephone interview 90 days after ICU discharge of corresponding patient. It si a scale ranging from 0 to 88. Weiss, DS.; Marmar, CR. The impact of event scale - revised. In: Wilson, JP.; Keane, TM., editors.Assessing psychological trauma and PTSD. New York: Guilford Press; 1997. p. 399-411
90 days
Secondary Outcomes (11)
PTSD Family members
90 days
PTSD Patients
90 days
PTSD healthcare providers
2 months after official end of the Covid-19 peak
HADS Family members
90 days
HADS Patients
90 days
- +6 more secondary outcomes
Study Arms (3)
Family members
* Age\>18y * Non-opposition to participate to the telephone interviews * One family member per patient: the family member the most implicated in the patient's care 3 groups of Family members will be enrolled in the study corresponding to patients with COVID-19, patients with seasonal flu and patients with community acquired pneumonia (See below). 1 family member per patient will be recruited.
Patients
Patients: * Age\>18y * Admission to the participating ICUs for any cause of acute respiratory failure during the COVID-19 pandemic * Having received invasive or noninvasive mechanical ventilation * Non-opposition to participate to the telephone interviews. 3 groups of patients will be enrolled in the study: patients with COVID-19, patients with seasonal flu and patients with community acquired pneumonia. * COVID group : Patients admitted to the ICU for acute respiratory failure and having a positive 2019-nCOV RT PCR in a respiratory / nasal swab sample (GROUP COVID-19) * Group FLU : patients admitted to the ICU for acute respiratory failure and having a confirmed influenza pneumonia * Group CAP (Community-acquired pneumonia) : patients admitted to the ICU for acute respiratory failure and having a clinically or microbiologically documental community acquired pneumonia with negative COVID-19 and Influenza PCRs.
healthcare providers
Two months after the official end of the COVID-19 peak in France, the local investigator will receive a set of 100 questionnaires. He/she will be responsible for proposing survey participation to volunteer healthcare providers. Those who are interested will be given the information letter and the questionnaires in an envelope. Once completed anonymously, they will seal the envelope and give it to the local investigator who will then send us all completed questionnaires by registered post.
Interventions
family members: post-traumatic stress disorder (PTSD) related symptoms assessed by Impact of Event Scale Revised (IES-R) at 90 days Patients: post-traumatic stress disorder (PTSD) related symptoms assessed by Impact of Event Scale Revised (IES-R) at 90 days
Symptoms of burnout as assessed by the Maslash Burnout Inventory
Eligibility Criteria
Family members, Patients hospitalized in ICU for COVID19 infection. Healthcare providers involved in care of patients hospitalized in ICU for COVID19 infection.
You may qualify if:
- Patients:
- Age\>18y
- Admission to the participating ICUs for any cause of acute respiratory failure during the COVID-19 pandemic
- Having received invasive or noninvasive mechanical ventilation
- Non-opposition to participate to the telephone interviews.
- Family members:
- Age\>18y
- Non-opposition to participate to the telephone interviews
- One family member per patient: the family member the most implicated in the patient's care
- Healthcare providers:
- All nurses and physicians (including those in training) in the participating ICUs during the COVID-19 pandemic
You may not qualify if:
- Patients:
- Language barrier to be able to respond to the telephone interview
- Cognitive disorders disabling patients to respond to the telephone interview
- Person under legal protection (1121-8 of CSP, Public Health Code) Failure to obtain the non-opposition
- Family members:
- Language barrier to be able to respond to the telephone interview
- Person under legal protection (1121-8 of CSP, Public Health Code)
- Failure to obtain the non-opposition
- Healthcare providers:
- Failure to obtain the non-opposition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Cochin
Paris, France
Pitié Salpetrière
Paris, France
Saint-Louis Hospital
Paris, Île-de-France Region, 75010, France
Related Publications (1)
Azoulay E, Resche-Rigon M, Megarbane B, Reuter D, Labbe V, Cariou A, Geri G, Van der Meersch G, Kouatchet A, Guisset O, Bruneel F, Reignier J, Souppart V, Barbier F, Argaud L, Quenot JP, Papazian L, Guidet B, Thiery G, Klouche K, Lesieur O, Demoule A, Guitton C, Capellier G, Mourvillier B, Biard L, Pochard F, Kentish-Barnes N. Association of COVID-19 Acute Respiratory Distress Syndrome With Symptoms of Posttraumatic Stress Disorder in Family Members After ICU Discharge. JAMA. 2022 Mar 15;327(11):1042-1050. doi: 10.1001/jama.2022.2017.
PMID: 35179564DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Elie AZOULAY, MD PhD
APHP
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 7, 2020
First Posted
April 10, 2020
Study Start
April 6, 2020
Primary Completion
November 30, 2020
Study Completion
December 31, 2021
Last Updated
October 6, 2020
Record last verified: 2020-10